Close Menu

NEW YORK – A real-time PCR assay from Bioneer to detect hepatitis C virus has received the CE mark, the firm said on Thursday.

The AccuPower HCV Quantitative RT-PCR Kit quantifies HCV viral RNA from blood samples using Bioneer's semi-automated real-time qPCR molecular diagnostic system, called ExiStation, which is CE marked and therefore eligible for procurement under World Health Organization criteria, the firm said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.